[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100331933":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":49,"collaborators":51,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":67,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Niguarda Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"EmboTrap ® II Device",null,"The study group consists of the patients with acute ischemic stroke from large vessel occlusion treated with EmboTrap ® II Device (Neuravi)",[13],"Device: Mechanical thrombectomy with EmboTrap ® II Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Mechanical thrombectomy with EmboTrap ® II Device","Endovascular treatment with mechanical thrombectomy using EmboTrap ® II Device (Neuravi)",[9],[21,27],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Edoardo Boccardi, MD","CONTACT","00396444","2772","edoardo.bocccardi@ospedaleniguarda.it",{"name":28,"role":23,"phone":24,"phoneExt":25,"email":29},"Luca Valvassori, MD","luca.valvassori@gmail.com",[31],{"facility":32,"status":33,"city":34,"state":10,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"ASST GOM Niguarda","RECRUITING","Milan","20162","Italy","IT",{"type":39,"coordinates":40},"Point",[41,42],12.59836,42.78235,{"lat":42,"lon":41},[45],{"name":22,"role":23,"phone":46,"phoneExt":47,"email":48},"+39026444","1","edoardo.boccardi@ospedaleniguarda.it",{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[52],{"name":53,"class":54},"Neuravi Limited","INDUSTRY","100331933","embotrap--ii-revascularization-device-neuravi-in-acute-ischemic-stroke-100331933",false,"NCT03601702","EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke","Multicentric Observational Prospective Study on the Use of the EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke","Inclusion Criteria\n\n* Signed Informed Consent Form\n* Large Vessel Occlusion on CTA or MRA in the Anterior or Posterior Proximal Cerebral Vasculature up to A1, M1, Dominant M2, P1\n* ASPECTS ≥ 6\n* Mismatch or good collaterals showed at MR or multiphasic CTA or pCT\n* Groin Puncture performed within 12 hours from symptom onset\n* Use of EmboTrap® II Revascularization Device (Neuravi) as the first or second line treatment\n\nExclusion criteria\n\n* Informed consent not given\n* Extracranial or tandem occlusion","ALL","18 Years",{"count":65,"type":66},100,"ESTIMATED","3 Months","OBSERVATIONAL","The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.",[71],"Acute Ischemic Stroke",[73,74,75,76],"acute ischemic stroke","endovascular treatment","stent retriever device","mechanical thrombectomy","2026-04-13",{"date":79,"type":80},"2026-04-16","ACTUAL",{"date":82,"type":80},"2022-01-01",{"date":84,"type":66},"2027-06-15",{"name":5,"class":6},1]